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Abst ract
Nemaline myopathy (NM) is a genetically and clinically het-
erogeneous muscle disorder, defined by the presence of char-
acteristic nemaline bodies on muscle biopsy. The disease has
a wide spectrum of phenotypes, ranging from forms with
neonatal onset and fatal outcome to asymptomatic forms. 
The neonatal form is severe and usually fatal. The clinical
variability, with differing age of onset and severity of symp-
toms makes the diagnosis difficult during infancy. There is
no curative treatment. L-tyrosine may prevent aspiration by
reducing pharyngeal secretions and drooling. Most of the
patients die from respiratory and cardiac failure.
This article discusses a newborn infant who presented with
generalized weakness and respiratory failure. Partial respon-
se to L-tyrosine treatment was noted. The case is worth pre-
senting to remind clinicians of congenital myopathies in the
differential diagnosis of floppy infant during neonatal period
and to emphasize the importance of muscle biopsy in dia-
gnosis.
Key words: congenital, myopathy, nemaline body, floppy,
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Nemaline myopathy in a newborn infant: a rare muscle disorder 
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CASE REPORT/OPIS PRZYPADKU
St reszc zenie
Miopatia nemalinowa jest schorzeniem miêœni, niejednorod-
nym pod wzglêdem genetycznym i klinicznym. Chorobê
cechuje obecnoœæ charakterystycznych struktur nemalino-
wych w bioptacie miêœnia. Fenotyp jest bardzo zró¿nicowa-
ny i obejmuje zarówno postacie noworodkowe prowadz¹ce
do zgonu, jak i postacie bezobjawowe. Postaæ noworodkowa
przebiega ciê¿ko i zwykle koñczy siê œmierci¹. Zmiennoœæ kli-
niczna, ³¹cznie ze zró¿nicowanym wiekiem w chwili wyst¹pie-
nia objawów i z ró¿nym ich nasileniem, mo¿e utrudniaæ roz-
poznanie w wieku niemowlêcym. Choroba jest nieuleczalna.
Podawanie L-tyrozyny mo¿e zapobiec zach³yœniêciu poprzez
zmniejszenie produkcji wydzieliny w gardle i œliny. Wiêk-
szoœæ chorych umiera z powodu niewydolnoœci oddechowej
i kr¹¿enia.
W artykule omówiono przypadek noworodka z uogólnionym
niedow³adem i niewydolnoœci¹ oddechow¹. Reakcja na poda-
wanie L-tyrozyny by³a czêœciowa. Przedstawiony opis przy-
padku ma na celu przypomnienie klinicystom o miopatiach
wrodzonych, które nale¿y uwzglêdniaæ w rozpoznaniu ró¿nico-
wym zespo³u wiotkiego dziecka w okresie noworodkowym,
oraz podkreœlenie znaczenia biopsji miêœnia w ustalaniu roz-
poznania. 
S³owa kluczowe: wrodzona, miopatia, struktury ne malinowe,
wiotkie, niemowlê.
Correspondence address: Ozgur Olukman, MD, Dr. Behçet Uz Children’s Hospital, Department of Neonatology, 1374 sk. no: 11, Alsancak, 35220 Izmir,
Turkey, e-mail: drolukman2002@yahoo.com
Received: 30.07.2012; accepted: 23.01.2013
Neurologia i Neurochirurgia Polska 2013; 47, 5494
Ozgur Olukman, Sebnem Calkavur, Gulden Diniz, Aycan Unalp, Fusun Atlihan
Introduction
Nemaline myopathy (NM) is a rare and heteroge-
nous form of congenital myopathy which usually pre-
sents in infancy or early childhood with hypotonia, slow-
ly progressive weakness of the facial, bulbar, proximal
limb and respiratory muscles, lax ligaments, areflexia
and skeletal deformities. Bulbar dysfunction causes swal-
lowing difficulties and drooling, and may predispose to
aspiration of oral secretions [1]. 
The clinical variability, with differing age of onset
and severity of symptoms makes the diagnosis difficult
in some cases [2]. Up till now, six different forms have
been described [3]. Type of inheritance may be autoso-
mal dominant, autosomal recessive and X-linked dom-
inant.
Muscle enzymes are usually normal, but may be mild-
ly elevated in some cases. Electromyography (EMG) is
nonspecific. Muscle imaging is useful in distinguishing
between neuropathic and myopathic processes. Muscle
biopsy is diagnostic. Biopsy specimens show numerous
threads like inclusions on modified Gomori trichrome
staining [4].
Treatment is supportive. L-tyrosine may prevent
aspiration by reducing pharyngeal secretions and drool-
ing [5]. Pneumonia due to aspiration occurs frequent-
ly. Most of the patients die from respiratory and cardiac
failure during infancy. 
Here we report a newborn baby who was admitted
to our neonatal intensive care unit (NICU) with severe
respiratory failure and generalized muscle weakness and
diagnosed as NM on muscle biopsy. The case was found
worth presenting in order to remind clinicians of neona-
tal muscle disorders in the differential diagnosis of severe
hypotonia during neonatal period. 
Case report
A newborn baby who was born from the first preg-
nancy of a 29-year-old mother by vaginal delivery on
the 36th gestational week was admitted to our NICU
because of severe respiratory failure soon after birth. His
family history did not reveal any significance in terms
of neuromuscular disesases and there was no consan-
guinity between his parents. His antenatal screening tests
were normal. However, fetal movements in the third
trimester of pregnancy felt by his mother and observed
by the obstetrician on the fetal ultrasonography were
decreased and marked polyhydramnios had emerged
after the 32nd week of pregnancy. At 36 weeks vaginal
delivery had to be induced because of the onset of mem-
bra rupture and fetal distress. 
Although the mother had not received any medica-
tion before or during delivery, the neonate had general-
ized hypotonia, severe dyspnea, bradycardia and central
cyanosis at birth. The Apgar scores at 1 and 5 minutes
were 2 and 6, respectively. He required immediate face
mask/bag resuscitation in the delivery room. On admis-
sion to our NICU, weak chest and diaphragmatic move-
ments, central cyanosis and generalized muscle weak-
ness were identified. The infant lied in a frog-like
position with abduction of the hips and an abnormal
extension of the limbs. When pulled to sitting position,
there was a remarkable head lag. In vertical suspension
his arms and legs were extended and on horizontal sus-
pension his head and limbs hung loosely. Except his eye
movements, he did not have any spontaneous move-
ments. Deep tendon reflexes were absent and neonatal
reflexes including sucking and swallowing were
decreased. No abnormal primitive reflex could be detect-
ed. Assessment of sensation did not reveal any patholo-
gy. He did not have any dysmorphic features or con-
genital defects. His karyotype was 46, XY. Widespread
fine crackles were auscultated over both lungs. Because
of severe respiratory failure, an endotracheal tube was
placed and he was started on mechanical ventilation.
Chest radiography revealed bilateral reticulogranular
pattern and decreased lung ventilation. His blood gas-
es were compatible with respiratory acidosis. He received
single dose of surfactant and he was started on dual
antibiotherapy with ampicillin and netilmicin. Routine
haematological and biochemical examinations were com-
pletely normal. Serial transfontanel ultrasonographic
examinations performed in consideration of birth
asphyxia on the first, third, seventh and fourteenth days
of life were assessed to be normal. No pathology could
be seen on his electroencephalographic examination
either. Echocardiography revealed restrictive patent duc-
tus arteriosus, patent foramen ovale and mild pulmonary
hypertension. Because of his ongoing severe hypotonia,
weak cry and no effort to breath, muscle enzymes and
screening tests for congenital metabolic disorders were
performed and they were found to be completely nor-
mal. EMG or cerebrospinal magnetic resonance imag-
ing (MRI) could not be performed because of his
dependency on mechanical ventilation. Eventually, in
order to exclude congenital neuromuscular disorders,
a muscle biopsy was performed from gastrocnemius at
age 8 weeks and the diagnosis of NM was established.
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Microscopic examination revealed the intracellular accu-
mulation of thread-like structures. The rods were not
visible on hematoxylin-eosin staining, but appeared as
red or purple structures against the blue-green myofib-
rillar background with the modified Gomori trichrome
stain (Fig. 1). The distribution of rods within myofibers
showed a tendency to cluster around nuclei. Further-
more an increased oxidative enzyme activity with
cytochrome oxidase enzyme stain was also demonstrat-
ed (Fig. 2). Immunohistochemical stainings were done
by streptavidin-biotin immunoperoxidase complex me -
thod using antibody against sarcomeric actin, smooth
muscle actin, desmin and vimentin. Only focal desmin
positivity could be demonstrated on these rods (Fig. 3).
There was diffuse positivity in all muscle fibers with the
antibody against myosin heavy chain neonatal. Genetic
analysis for specific gene mutations could not be per-
formed. Diagnosis was based on clinical findings and
the observation of characteristic rod-shaped structures
(nemaline bodies) on muscle biopsy. 
Although he had received daily physiotherapy, he
developed generalized muscle atrophy on follow up. He
had profuse sialorrhoea from birth and required fre-
quent suctioning. He experienced 8 aspiration pneu-
monitis attacks and he developed permanent atelectasis
on his right lung. Despite of many extubation attempts
he could not tolerate spontaneous respiration and he was
kept on intermittent positive-pressure ventilation until
his death. He was also dependent on orogastric feeding
and parenteral nutrition throughout his hospital stay.
Treatment of L-tyrosine was begun at 3 months of age
(250 mg daily) and resulted in a marked improvement
in his oral secretions and muscle strength. Unfortu-
nately, he passed away because of a sudden cardiorespi-
ratory failure after an attack of aspiration at 4 months
of age.
Discussion
Almost any condition that affects the central or pe -
ripheral nervous system of a newborn can be expressed
by hypotonia. Furthermore, most acute or multisystem
illnesses in neonates are accompanied by some degree
of hypotonia. Therefore clinicians must consider whet -
her the infant is acutely ill from sepsis, organ failure,
metabolic dysfunction, or other systemic illness. If these
illnesses are not present as so in our case, the next step
is to consider whether a primary disorder of the central
or peripheral nervous system is the cause. 
Fig. 1. Modified Gomori trichrome stain showed characteristic purple-colored
rods in the perinuclear region
Fig. 2. Increased oxidative enzyme activity with cytochrome oxidase enzyme
stain 
Fig. 3. Focal desmin positivity on immunohistochemical staining (streptavi-
din-biotin immunoperoxidase complex method)
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The differential diagnosis between a primary central
nervous system disorder and a neonatal muscle disor-
der requires a methodical approach including a detailed
family, obstetric and delivery history and a careful exam-
ination. Clues to the presence of a neuromuscular dis-
order include polyhydramnios, decreased fetal move-
ments and malpresentation. Physical findings such as
respiratory failure with decreased or absent diaphrag-
matic movements, typical frog-like body posture, de -
creased or absent spontaneous extremity movements,
absence of abnormal primitive reflexes, absence of deep
tendon reflexes, findings of bulbar dysfunction such as
weak cry, poor suck and swallow reflexes, pooling of
secretions and aspiration can all be interpreted in favour
of a congenital muscle disorder. Afterwards, a muscle
biopsy should be performed to prove the diagnosis.
Most of these above mentioned clues and physical find-
ings were present in our patient. Therefore we per-
formed a muscle biopsy from gastrocnemius at age 
8 weeks and diagnosed NM.
Nemaline myopathy is a genetically and clinically 
heterogenous muscle disorder which is characterized 
by severe muscle weakness and nemaline rod bodies in
skeletal muscle fibers. The term “nemaline” was first used
by Shy and his colleagues in 1963 who reported a new
type of nonprogressive myopathy characterized by numer-
ous thread-like structures within the muscle fibers [6].
Clinically, six different forms of NM have been de -
scribed until today [3,4,7]. A classic/typical congenital
form (46%) may appear as a floppy infant with addi-
tional facial and respiratory weakness. A severe con-
genital (neonatal) form (16%) is marked by lack of fetal
movements and by respiratory insufficiency. Patients
usually present at birth with severe muscle weakness,
difficulties with sucking and swallowing. Contractures,
fractures, arthrogryposis multiplex and dilated car-
diomyopathy may also be associated. Most neonates suf-
fer from hypoxia and usually require invasive ventilato-
ry support. The intermediate congenital form (20%)
with clinical severity apparent only later in the infantile
period is characterized by generalized hypotonia, weak-
ness and a very thin muscle mass. Muscles of the jaw
may be too weak to hold it closed. Pooling of the oral
secretions in the mouth is common and this may pre-
dispose to aspiration pneumonitis. Expressions of the
other three forms (mild childhood or adolescent-onset
form [13%], adult-onset [late-onset] form [4%] and
the form with diverse features [< 1%]) are not appar-
ent during the neonatal period. Our patient mostly met
the criteria for the severe congenital form.
Dilated or hypertrophic cardiomyopathy is an un -
common complication of the disease [8-10]. Nemaline
bodies clustered in the cardiac muscle can be demon-
strated hystologically. Some authors have also described
an unusual course of the disease with late onset scapulo-
humeral syndrome [11]. Our patient had undergone
five echocardiographic examinations throughout his hos-
pitalization and no associated cardiac involvement could
be demonstrated.
Muscle enzymes are usually normal, but may be
mildly elevated in some cases. EMG is nonspecific,
showing similar abnormalities in all congenital myo -
pathies. Especially before the age of 3 years, EMG usu-
ally shows mild abnormalities and a myopathic pattern
can be found in only a few patients [12]. Muscle imag-
ing is useful in distinguishing between neuropathic and
myopathic processes, and can be used to identify an
appropriate muscle to biopsy. Muscle MRI commonly
reveals patchy, fatty degeneration of muscle tissue and
variable involvement of different muscle groups [13].
Neither EMG, nor MRI are necessary for definite diag-
nosis. They are accepted as useful tools in making dif-
ferential diagnosis. Repeated muscle enzymes, EMG
and MRI (craniospinal) of our patient were completely
normal. 
Muscle biopsy is diagnostic. Biopsy specimens show
numerous threads like inclusions on modified Gomori
trichrome staining [4,14]. Based upon additional actin
aggregates, three different histological subgroups of
patients can be identified [4,15]. Intranuclear nemaline
rods correlate with severe clinical manifestations and
poor prognosis [16]. Similarly focal myofibrillar degen-
eration and increase in lysosomal enzymes may indicate
poor prognosis. At this point, we should mention that
myosin heavy chain has many isoforms which are spe-
cific for different muscle fibre types and some of which
are developmentally regulated. Neonatal myosin has
been described as one type of myosin heavy chain. It is
known to be expressed in human striated muscles dur-
ing the fetal period of human muscle development.
Therefore expression of neonatal myosin in the postna-
tal period is accepted as an immaturity sign. In this
respect, Fidziañska et al. [17] have described an infant
with a neonatal form of nemaline myopathy showing
ultrastructural features of muscle immaturity such as
abnormal presence of myotubes, as well as cells in clus-
ters within a common basement membrane and a great
number of satellite cells adhering to very small muscle
fibers. The muscle biopsy of our patient revealed intra-
cellular clustered nemaline rods with apparently lacking
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actin aggregates on trichrome stain and increased oxida-
tive enzyme activity with COX. Immunohistochemical
stainings demonstrated focal desmin positivity. We also
detected diffuse neonatal myosin expression and accept-
ed it as a sign of immaturity. 
Genetically, causative mutations have been described
in five genes encoding different skeletal muscle thin fil-
ament proteins. These filamental proteins and their
encoding genes are: sarcomeric actin (ACTA1), alpha-
tropomyosin (TPM3), beta-tropomyosin (TPM2), tro-
ponin T1 (TNNT1) and nebulin (NEB) [18,19]. Neb-
ulin gene mutations are seen most commonly in
autosomal recessive cases and these patients present as
typical congenital NM [20,21]. Unfortunately we could
not perform genetic analysis of our patient.
Therapeutic strategies for NM are symptomatic and
empirical. Orogastric/nasogastric/nasojejunal tube feed-
ing and gastrostomy may be needed for chronic dys-
phagia and sucking-swallowing difficulty. Pneumonia
due to aspiration of oral secretions occurs frequently.
Treatments for sialorrhoea, such as anticholinergic agents
and salivary gland botulinum toxin injections, are often
ineffective or associated with significant side effects [22].
Dietary L-tyrosine supplementation may improve bul-
bar functions and increase catecholamine-mediated sym-
pathetic activity in the salivary glands [5]. By this way,
it may reduce pharyngeal secretions and thus prevent
drooling and aspiration. Our patient was dependent on
orogastric feeding and parenteral nutrition throughout
his hospital stay. Despite of many extubation attempts,
he could not tolerate spontaneous respiration and he was
dependent on intermittent positive-pressure ventilation.
He experienced 8 attacks of aspiration pneumonitis until
L-tyrosine treatment (250 mg daily) was started on at 
3 months of age. L-tyrosine treatment resulted in
a marked improvement in his oral secretions and mus-
cle strength. However it could not detain him from
developing upper right lung atelectasis due to previous
aspirations. 
Many of the patients die from respiratory and car-
diac failure during infancy [23]. Unfortunately, there
is no curative treatment modality. In conclusion, keep-
ing in mind NM in the differential diagnosis of floppy
infant and offering genetic counselling to families for
consequent pregnancies seems to be the only way to pre-
vent this genetic disorder at present.
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